ArticlePharmacoepidemiology and drug safety2022

Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design.

Jim Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.